Crossject reports successful completion of European and U.S. audits for manufacturing of ZENEO® Midazolam for epileptic seizures Press Release Crossject reports successful completion of European and U.S. audits for manufacturing of ZENEO® Midazolam for epileptic seizures ISO 13485 certification renewed for manufacturing...

CROSSJECT - CLINICAL DEMONSTRATION OF ZENEO® EFFICIENCY FOR INTRAMUSCULAR INJECTION OF MIDAZOLAM Press release CLINICAL DEMONSTRATION OF ZENEO® EFFICIENCY FOR INTRAMUSCULAR INJECTION OF MIDAZOLAM • Primary endpoints met and results in line with expectations• No impact of clothing on the...

CROSSJECT - Validation clinique de l’efficacité de ZENEO® pour l’injection intramusculaire de midazolam Communiqué de presse Validation clinique de l’efficacité de ZENEO® pour l’injection intramusculaire de midazolam • Paramètres primaires atteints et résultats conformes aux attentes Pas d’impact du...